Chikungunya Vaccine Candidate 'VLA1553' set to enter Phase 3 Study

Chikungunya is considered to be a major public health threat by the World Health Organization. A speciality vaccine...

June 2, 2020 | Tuesday | News
Moderna Advances in Platform Science and Innovative Vaccine Research

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to creat...

June 2, 2020 | Tuesday | News
Moderna finalizing protocol for Ph 3 study of COVID-19 vaccine

US based Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...

June 4, 2020 | Thursday | News
Intravacc, EpiVax to develop novel COVID-19 vaccine

The Netherlands-based Intravacc, one of the world's leading translational research and development vaccine ins...

June 3, 2020 | Wednesday | News
IAVI, Merck to develop vaccine against SARS-CoV-2

Merck, known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicat...

May 29, 2020 | Friday | News
Novavax begins Ph 1/2 trial of COVID-19 vaccine

US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...

May 28, 2020 | Thursday | News
Vaxine announces COVID-19 vaccine collaboration with Medytox

Vaxine Pty Ltd., Adelaide, Australia announced that it has entered into a formal collaboration with Medytox Inc., a Kore...

May 27, 2020 | Wednesday | News
PharmaJet, Abnova to use needle-free injection technology for COVID-19 vaccine

US based PharmaJet®, the maker of innovative, needle-free injection technology, has announced that its Needle-free I...

May 25, 2020 | Monday | News
Sinovac secures $15 M for COVID-19 vaccine development

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced a transaction in which Ad...

May 25, 2020 | Monday | News
AGC Biologics partners with Takara Bio in COVID-19 fight

Denmark headquartered AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmace...

May 22, 2020 | Friday | News
Moderna's COVID-19 vaccine shows positive interim Ph 1 results

US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...

May 20, 2020 | Wednesday | News
Japan to design personalized cancer vaccine

Transgene, a biotech company in Tokyo that designs and develops virus-based immunotherapies for the treatment of cancer,...

May 15, 2020 | Friday | News
Moderna's COVID-19 vaccine enters Ph 2 trial

US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...

May 14, 2020 | Thursday | News
Pfizer, BioNTech initiate human trials with COVID-19 mRNA Vaccine

Pfizer Inc. and BioNTech SE  announced on 5 May 2020 that the first participants have been dosed in the U.S. in the...

May 7, 2020 | Thursday | News
CEPI invests $3.5M in Clover Australia for COVID-19 vaccine

Norway based CEPI, the Coalition for Epidemic Preparedness Innovations has announced a ninth worldwide collaboration to ...

May 1, 2020 | Friday | News
NanoPass joins pharma partners for COVID-19 vaccine development

Novel Coronavirus presents a global pandemic with unprecedented medical, economic and social scales. Since there is curr...

April 27, 2020 | Monday | News
CanSino Bio enrols for Ph 2 trial of COVID-19 vaccine

China’s CanSino Biologics advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making this vaccine c...

April 27, 2020 | Monday | News
NEC designs blueprints for COVID-19 vaccines using AI

Japan based NEC Corporation has announced analysis results from efforts using AI prediction platforms to design blueprin...

April 24, 2020 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls